Fujifilm Diosynth Biotechnologies has opened its new Flexible Manufacturing Facility (FBF) in College Station, Texas.

The 80,000 square foot facility utilizes state-of-the-art Mobile Clean Room technology to allow for multiproduct and multi-class production of Advanced Therapies. 

“With flexibility at the core of its design, the FBF can produce both clinical and commercial therapeutics; it is ready to make batches today and is capable of rapid expansion to meet the growing demands of the industry,” said Martin Meeson, president and chief operating officer of Fujifilm.

The FBF adds to their existing Process and Analytical development and manufacturing capabilities at National Centre for Therapeutic Manufacturing, which is equipped for Phase I/II GMP production of Advanced Therapies.